Clinical efficacy of riboflavin and ultraviolet light inactivated fresh frozen plasma evaluated with INR-quantification
Authors:
- Bela BalintBBBela Balint
- Ana AnticAAAna Antic
- Milena TodorovicMTMilena Todorovic
- Gordana OstojicGOGordana Ostojic
- Mirjana PavlovicMPMirjana Pavlovic
- 1 August 2012
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 47 (1) , 33-37
Abstract
No abstract availableKeywords
Funding Information
- Ministarstvo Prosvete, Nauke i Tehnološkog Razvoja (41031)
This publication has 15 references indexed in Scilit:
- Effects of use of riboflavin and ultraviolet light for pathogen inactivation on quality of platelet concentratesVojnosanitetski Pregled, 2011
- Mirasol PRT system inactivation efficacy evaluated in platelet concentrates by bacteria-contamination modelVojnosanitetski Pregled, 2011
- Rapid determination of vitamin B2 (riboflavin) in plasma by HPLCClinica Chimica Acta, 2011
- Characterization of plasma protein activity in riboflavin and UV light-treated fresh frozen plasma during 2 years of storage at −30°CVox Sanguinis, 2010
- Design and development of a method for the reduction of infectious pathogen load and inactivation of white blood cells in whole blood productsBiologicals, 2010
- Pathogen reduction technology (Mirasol®) treated single‐donor platelets resuspended in a mixture of autologous plasma and PASVox Sanguinis, 2009
- Toxicity Testing of a Novel Riboflavin-Based Technology for Pathogen Reduction and White Blood Cell InactivationTransfusion Medicine Reviews, 2008
- Pathogen InactivationAmerican Journal of Clinical Pathology, 2007
- Pathogen inactivation: making decisions about new technologiesTransfusion, 2007
- The Mirasol™ PRT system for pathogen reduction of platelets and plasma: An overview of current status and future trendsTransfusion and Apheresis Science, 2006